Price | 1W % | 1M % | 3M % | 6M % | 1Y % | YTD % |
|---|---|---|---|---|---|---|
-- | -- | -- | -- | -- | -- | -- |
AI Generated Qualitative Analysis
Your time is precious, so save it. Use AI to get the most important information from the business.
Learn about Cosmos Health Inc.
Cosmos Health Inc. News
Jun 24, 2025 - globenewswire.com
Cosmos Health Enters U.S. Market with Strategic Made-in-America Manufacturing, Mitigating Tariff Risks; Executes Agreement with New Jersey-Based DolCas Biotech
May 15, 2025 - globenewswire.com
RETRANSMISSION – Cosmos Health Reports Q1 2025 Results: Adjusted Profitability Achieved as Gross Profit Rises 54% to $2.05M; Operating Cash Burn Down 95%, or $3.2M, to $0.19M; Approaching Cash Flow Breakeven
May 15, 2025 - globenewswire.com
Cosmos Health Reports Q1 2025 Results: Adjusted Profitability Achieved as Gross Profit Rises 54% to $2.05M; Operating Cash Burn Down 95%, or $3.2M, to $0.19M; Approaching Cash Flow Breakeven
May 7, 2025 - globenewswire.com
Cosmos Health Secures Follow-Up Order from Pharmalink for 80,000 Sky Premium Life Units in the UAE; Initial 130,000-unit Order Sold Out, Advancing 5-Year Goal of Over 3 Million Units
Cosmos Health Inc. Quantitative Score
About Cosmos Health Inc.
Cosmos Health Inc. operates as a vertically integrated pharmaceutical company. It offers a proprietary line of branded and generic pharmaceuticals, nutraceuticals, over-the-counter medications, health care and baby products, medical devices, and other products through its distribution channels and an ecommerce marketplace. The company identifies, acquires, develops, and commercializes products that enhance patients' lives and outcomes, as well as has distribution centers in Greece and the United Kingdom; and operates a warehousing facility. It serves wholesale pharmaceutical distributors and independent retail pharmacies. Cosmos Health Inc. was incorporated in 2009 and is headquartered in Chicago, Illinois.
Cosmos Health Inc. Earnings & Revenue
What’s This Company Really Worth? Find Out Instantly.
Warren Buffett’s go-to valuation method is Discounted Cash Flow (DCF). Our tool makes it effortless — no spreadsheets, just answers in a few clicks.
Cosmos Health Inc. Financials
Table Compare
Compare COSM metrics with: | |||
|---|---|---|---|
Earnings & Growth | COSM | None | |
EPS (TTM) YoY Growth | -- | -- | |
Revenue (TTM) YoY Growth | -- | -- | |
Valuation (TTM) | COSM | None | |
Price/Earnings Ratio | -- | -- | |
Price/Sales Ratio | -- | -- | |
Profitability & Efficiency (TTM) | COSM | None | |
Net Profit Margin | -- | -- | |
Return on Equity | -- | -- | |
Financial Health (TTM) | COSM | None | |
Debt/Assets Ratio | -- | -- | |
Assets/Liabilities Ratio | -- | -- | |
Cosmos Health Inc. Income
Cosmos Health Inc. Balance Sheet
Cosmos Health Inc. Cash Flow
Cosmos Health Inc. Financials Over Time
Analysts Rating
Strong Buy
Buy
Hold
Sell
Strong Sell
Metrics Scores
| Metrics | Score |
|---|---|
| Discounted Cash Flows | Strong Buy |
| Return on Equity | Strong Sell |
| Return on Assets | Strong Sell |
| Debt/Equity Ratio | Sell |
| Price/Earnings Ratio | Strong Sell |
| Price/Book Ratio | Strong Buy |
Price Targets
Disclaimer: This 3rd party analysis information is for reference only and does not constitute investment advice.
Historical Market Cap
Shares Outstanding
Cosmos Health Inc. Executives
| Name | Role |
|---|---|
| Mr. Grigorios Siokas | Chairman & Chief Executive Officer |
| Mr. Georgios Terzis | Chief Financial Officer |
| Mr. Nikolaos Bardakis | Chief Operating Officer |
| Mr. Demetrios G. Demetriades | Secretary & Independent Director |
| Prof. Dimitrios Trafalis | Head of Oncology |
| Name | Role | Gender | Date of Birth | Pay |
|---|---|---|---|---|
| Mr. Grigorios Siokas | Chairman & Chief Executive Officer | Male | 1965 | 1.48M |
| Mr. Georgios Terzis | Chief Financial Officer | Male | 1983 | 266.7K |
| Mr. Nikolaos Bardakis | Chief Operating Officer | Male | 1969 | 52.79K |
| Mr. Demetrios G. Demetriades | Secretary & Independent Director | Male | 1965 | 15K |
| Prof. Dimitrios Trafalis | Head of Oncology | -- |
Cosmos Health Inc. Insider Trades
| Date | 23 May |
| Name | Siokas Grigorios |
| Role | Chief Executive Officer |
| Transaction | Acquired |
| Type | P-Purchase |
| Shares | 34004 |
| Date | 22 May |
| Name | Siokas Grigorios |
| Role | Chief Executive Officer |
| Transaction | Acquired |
| Type | P-Purchase |
| Shares | 141825 |
| Date | 21 May |
| Name | Siokas Grigorios |
| Role | Chief Executive Officer |
| Transaction | Acquired |
| Type | P-Purchase |
| Shares | 174172 |
| Date | 20 May |
| Name | Siokas Grigorios |
| Role | Chief Executive Officer |
| Transaction | Acquired |
| Type | P-Purchase |
| Shares | 147563 |
| Date | 19 May |
| Name | Siokas Grigorios |
| Role | Chief Executive Officer |
| Transaction | Acquired |
| Type | P-Purchase |
| Shares | 79254 |
| Date | Name | Role | Transaction | Type | Shares |
|---|---|---|---|---|---|
| 23 May | Siokas Grigorios | Chief Executive Officer | Acquired | P-Purchase | 34004 |
| 22 May | Siokas Grigorios | Chief Executive Officer | Acquired | P-Purchase | 141825 |
| 21 May | Siokas Grigorios | Chief Executive Officer | Acquired | P-Purchase | 174172 |
| 20 May | Siokas Grigorios | Chief Executive Officer | Acquired | P-Purchase | 147563 |
| 19 May | Siokas Grigorios | Chief Executive Officer | Acquired | P-Purchase | 79254 |